calcium + cholecalciferol béres 600 mg + 800 j.m. tabletki powlekane
beres pharmaceuticals ltd. - calcium + cholecalciferolum, pulvis - tabletki powlekane - 600 mg + 800 j.m.
peditrace novum produkt złożony koncentrat do sporządzania roztworu do infuzji
fresenius kabi ab - zinci chloridum + miedzi chlorek dwuwodny + natrii selenis + chlorek manganu czterowodny + kalii iodidum - koncentrat do sporządzania roztworu do infuzji - produkt złożony
norsept 400 mg tabletki powlekane
adamed pharma s.a. - norfloxacinum - tabletki powlekane - 400 mg
xofluza
roche registration gmbh - baloxavir marboxil - grypa, człowiek - Środki przeciwwirusowe do użytku ogólnoustrojowego - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.
unguentum zinci oxydati 100 mg/1 g maść
biowet drwalew sp. z o.o. - zinci oxidum - maść - 100 mg/1 g - bydło; koń; koza; owca; pies; świnia
levofloxacin genoptim 250 mg tabletki powlekane
synoptis pharma sp. z o.o. - levofloxacinum - tabletki powlekane - 250 mg
levofloxacin genoptim 500 mg tabletki powlekane
synoptis pharma sp. z o.o. - levofloxacini hemihydras - tabletki powlekane - 500 mg
levalox 250 mg tabletki powlekane
krka, d.d., novo mesto - levofloxacini hemihydras - tabletki powlekane - 250 mg
levalox 500 mg tabletki powlekane
krka, d.d., novo mesto - levofloxacini hemihydras - tabletki powlekane - 500 mg
revolade
novartis europharm limited - olamine - purpura, trombocytopenic, idiopatyczny - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.